ATE249211T1 - Behandlung von metastasierendem nicht auf hormonbehandlung ausprechendem prostatakrebs - Google Patents

Behandlung von metastasierendem nicht auf hormonbehandlung ausprechendem prostatakrebs

Info

Publication number: ATE249211T1
Authority: AT; Austria
Prior art keywords: treatment; prostate cancer; metastasic; responsible; cyclophosphamide
Prior art date: 1993-12-27

Application number

AT95902723T

Other languages

English (en)

Inventor

Lorne J Brandes

Original Assignee

Univ Manitoba

Manitoba Cancer Treat And Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-27

Filing date

1994-12-07

Publication date

2003-09-15

1994-12-07 Application filed by Univ Manitoba, Manitoba Cancer Treat And Res filed Critical Univ Manitoba

2003-09-15 Application granted granted Critical

2003-09-15 Publication of ATE249211T1 publication Critical patent/ATE249211T1/de

Links

206010060862 Prostate cancer Diseases 0.000 title abstract 2
208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 2
229940088597 hormone Drugs 0.000 title 1
239000005556 hormone Substances 0.000 title 1
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 abstract 3
229960004397 cyclophosphamide Drugs 0.000 abstract 3
QFMZQPDHXULLKC-UHFFFAOYSA-N 1,2-bis(diphenylphosphino)ethane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCP(C=1C=CC=CC=1)C1=CC=CC=C1 QFMZQPDHXULLKC-UHFFFAOYSA-N 0.000 abstract 1
230000001093 anti-cancer Effects 0.000 abstract 1
238000001802 infusion Methods 0.000 abstract 1
238000001990 intravenous administration Methods 0.000 abstract 1
208000010658 metastatic prostate carcinoma Diseases 0.000 abstract 1
230000001988 toxicity Effects 0.000 abstract 1
231100000419 toxicity Toxicity 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

AT95902723T 1993-12-27 1994-12-07 Behandlung von metastasierendem nicht auf hormonbehandlung ausprechendem prostatakrebs ATE249211T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/173,047 US5432168A (en)	1993-12-27	1993-12-27	Method of treatment of hormone-unresponsive metastatic prostate cancer
PCT/CA1994/000676 WO1995017887A1 (en)	1993-12-27	1994-12-07	Method of treatment of hormone-unresponsive metastatic prostate cancer

Publications (1)

Publication Number	Publication Date
ATE249211T1 true ATE249211T1 (de)	2003-09-15

Family

ID=22630304

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95902723T ATE249211T1 (de)	1993-12-27	1994-12-07	Behandlung von metastasierendem nicht auf hormonbehandlung ausprechendem prostatakrebs

Country Status (9)

Country	Link
US (1)	US5432168A (de)
EP (1)	EP0737067B1 (de)
JP (1)	JP3194525B2 (de)
AT (1)	ATE249211T1 (de)
AU (1)	AU699798B2 (de)
CA (1)	CA2179377C (de)
DE (1)	DE69433140T2 (de)
ES (1)	ES2210278T3 (de)
WO (1)	WO1995017887A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6506876B1 (en)	1994-10-11	2003-01-14	G.D. Searle & Co.	LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
US5585492A (en) *	1994-10-11	1996-12-17	G. D. Searle & Co.	LTA4 Hydrolase inhibitors
US5863912A (en) *	1994-12-07	1999-01-26	Manitoba Cancer Treatment And Research Foundation	Method of treatment of hormone-unresponsive metastiatic prostate cancer
US6241962B1 (en)	1996-06-24	2001-06-05	Dupont Pharmaceuticals Company	Radiopharmaceutical compositions and matrices and uses thereof
US6498181B1 (en)	1999-01-06	2002-12-24	Maxim Pharmaceuticals	Synergistic tumorcidal response induced by histamine
US8835506B2 (en)	2008-06-05	2014-09-16	Stc.Unm	Methods and related compositions for the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4829068A (en) *	1987-03-18	1989-05-09	University Of Manitoba	Treatment of disorders of the gastro-intestinal tract
EP0353692B1 (de) *	1988-08-02	1995-10-04	Nissan Chemical Industries Ltd.	Mittel zur Verbesserung von Arzneimitteleffekten für Antitumormittel
US4990538A (en) *	1989-08-23	1991-02-05	Harris Adrian L	Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
DE69103908T2 (de) *	1990-12-17	1995-01-05	University Of Manitoba, Winnipeg, Manitoba	Verbessertes behandlungsverfahren für krebs.
GB9303210D0 (en) *	1993-02-17	1993-03-31	Univ Manitoba	Cancer treatment

1993
- 1993-12-27 US US08/173,047 patent/US5432168A/en not_active Expired - Lifetime
1994
- 1994-12-07 AU AU11889/95A patent/AU699798B2/en not_active Ceased
- 1994-12-07 EP EP95902723A patent/EP0737067B1/de not_active Expired - Lifetime
- 1994-12-07 CA CA002179377A patent/CA2179377C/en not_active Expired - Fee Related
- 1994-12-07 JP JP51769495A patent/JP3194525B2/ja not_active Expired - Fee Related
- 1994-12-07 ES ES95902723T patent/ES2210278T3/es not_active Expired - Lifetime
- 1994-12-07 DE DE69433140T patent/DE69433140T2/de not_active Expired - Fee Related
- 1994-12-07 AT AT95902723T patent/ATE249211T1/de not_active IP Right Cessation
- 1994-12-07 WO PCT/CA1994/000676 patent/WO1995017887A1/en not_active Ceased

Also Published As

Publication number	Publication date
EP0737067A1 (de)	1996-10-16
ES2210278T3 (es)	2004-07-01
JP3194525B2 (ja)	2001-07-30
CA2179377A1 (en)	1995-07-06
CA2179377C (en)	2005-01-25
AU1188995A (en)	1995-07-17
US5432168A (en)	1995-07-11
WO1995017887A1 (en)	1995-07-06
JPH09506902A (ja)	1997-07-08
DE69433140T2 (de)	2004-07-08
AU699798B2 (en)	1998-12-17
DE69433140D1 (de)	2003-10-16
EP0737067B1 (de)	2003-09-10

Similar Documents

Publication	Publication Date	Title
ATE282425T1 (de)	2004-12-15	Verfahren zur behandlung von endothelialen verletzungen
DK1068870T3 (da)	2006-10-02	Antitumormidler
ES2179096T3 (es)	2003-01-16	Utilizacion de la interleucina-12 para prevenir la reaccion del injerto contra el huesped.
RU94041950A (ru)	1996-09-20	Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
DE69424537D1 (de)	2000-06-21	Therapeutischer wirkstoff zur behandlung von melanomen
ATE32730T1 (de)	1988-03-15	Indikatormarkierte konjugate von metallothionein und zielsuchenden, biologisch aktiven molekuelen.
ATE233738T1 (de)	2003-03-15	Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten
NZ285159A (en)	2000-10-27	Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene
ES2082198T3 (es)	1996-03-16	Inhibidores de esteroide-sulfatasa.
DE69429427D1 (de)	2002-01-24	Behandlung von tumoren mit verbindungen mit einer rxr-retinoid agonistische wirkung
DE68913638D1 (de)	1994-04-14	Behandlung von wässerigen Systemen.
DE3888378D1 (de)	1994-04-21	Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen.
MX9306960A (es)	1995-01-31	Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
KR930701175A (ko)	1993-06-11	인체 전립선 아데노카르시노마의 치료방법
ATE174785T1 (de)	1999-01-15	Behandlung von akne oder von folliculitis barbae
DE69631478D1 (de)	2004-03-11	Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE68907423D1 (de)	1993-08-12	Behandlung der akne.
FR2092743A1 (en)	1972-01-28	Complete extraction of total flavanol gomers from plats -peripheral - venous activity
ATE249211T1 (de)	2003-09-15	Behandlung von metastasierendem nicht auf hormonbehandlung ausprechendem prostatakrebs
DE69103693D1 (de)	1994-10-06	Behandlung von unterirdischen Formationen.
ATE201823T1 (de)	2001-06-15	Topische pharmazeutische zusammensetzungen, welche heparin enthalten
DE3770766D1 (de)	1991-07-18	Wirkstoffe zur anwendung bei der behandlung von tumoren.
DE69218200D1 (de)	1997-04-17	Behandlung von leberkrebs
ATE293972T1 (de)	2005-05-15	Behandlung von chronischen schmerzen
NO992985L (no)	1999-06-17	Anvendelse av COMT inhibitorer for fremstilling av et legemiddel til Õ forhindre diabetisk vaskulµr dysfunksjon

Legal Events

Date	Code	Title	Description
2004-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties